How much does margetuximab cost? What are the price differences in different regions or pharmacies?

Margetuximab (margetuximab) is a new type of anti-HER2 monoclonal antibody, mainly used for the treatment of patients with HER2-positive advanced breast cancer. Due to its short time on the market in China, the specific market price has not yet been determined, and it is not currently included in the scope of medical insurance. Therefore, patients need to consult the hospital or designated pharmacy to obtain the latest price information when purchasing drugs.

In overseas markets, margetuximab has been launched in many countries, including Europe and Japan. At present, the European and Japanese versions of the original drugs have been supplied to the market. The common specifications are 250mg/10ml*1bottles/boxes, and their market prices may be more than 30,000 yuan. Drug prices in different countries and regions may vary due to differences in medical systems, tax policies, and supply channels. Patients can choose the appropriate drug purchase channel according to their own circumstances.

Since margetuximab is still under patent protection, its generic version has not yet appeared on the market. Generic drugs are usually cheaper than brand-name drugs, but they need to go through a strict approval process before entering the market. At present, if patients want to use this drug, they can only choose the original drug, and cannot reduce the cost of treatment through generic drugs.

Overall, the price of margetuximab varies in different regions. The domestic market price has not yet been fully disclosed, while the overseas market has been relatively stable. For patients in need of treatment, it is recommended to consult a doctor in advance to understand the availability of drugs and the possible financial burden. At the same time, pay attention to the adjustment of medical insurance policies to obtain a more reasonable drug purchase plan.

Reference materials:https://www.margenza.com/

xa0